Section Arrow
Quote
IART.NASDAQ
- Integra LifeSciences Holdings Corp
Quotes are at least 15-min delayed:2025/04/29 23:59 EDT
Last
 17.35
+0.66 (+3.95%)
Day High 
17.54 
Prev. Close
16.69 
1-M High
22.27 
Volume 
1.06M 
Bid
16.72
Ask
17.97
Day Low
16.41 
Open
16.66 
1-M Low
14.45 
Market Cap 
1.29B 
Currency USD 
P/E 78.9 
%Yield -- 
10-SMA 16.17 
20-SMA 17.9 
50-SMA 20.74 
52-W High 32.66 
52-W Low 14.45 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.09/2.70
Enterprise Value
2.65B
Balance Sheet
Book Value Per Share
20.00
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
1.61B
Operating Revenue Per Share
19.97
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed：2025/04/29 23:59 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.